临床试验支援服务的全球市场规模、份额、成长分析（按阶段、按适应症）－产业预测，2024-2031

2022年全球临床试验支援服务市场规模将为208.6亿美元，预测期间（2024-2031年）复合年增长率为7.50%，从2023年的224.2亿美元成长到2031年的399.9亿美元2019年。

临床试验支援服务、分析设计和临床试验都非常有益。它还包括管理套件、计算药物剂量、保护临床试验地点以及保护和储存研究药物。临床前基础知识和研究由临床试验支援服务提供，包括临床试验现场支援、研究药物的获取和储存、研究药物的盲法、患者招募、协调以及返回药物的协调。 2021年，临床试验领域发生了重大变化。随着COVID-19疫苗接种的发展，许多因疫情而推迟的临床试验已经恢復。临床试验是创造治疗新药所必需的，这方面还有许多未满足的需求。这是因为开发中国家感染疾病、慢性病和热带疾病的发生率很高。虚拟临床试验的使用已成为大流行后该行业临床试验支援服务部门收益成长的主要驱动力。越来越多的临床研究公司正在转向虚拟技术来简化临床研究服务。

目录

执行摘要

• 市场概况
• 命运之轮

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 宏观经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管环境
• 波特的分析
• 对未来中断的特殊考虑

全球临床试验支援服务市场：按阶段

• 市场概况
• 第一阶段
• 二
• Ⅲ
• IV

全球临床试验支援服务市场：按适应症分类

• 市场概况
• 自体免疫/发炎
• 肿瘤学
• 糖尿病
• 心血管

全球临床试验支援服务市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• IQVIA Holdings Inc.
• PAREXEL International Corporation（a subsidiary of Pamplona Capital Management）
• Charles River Laboratories International Inc.
• PRA Health Sciences Inc.
• ICON Plc
• Syneos Health Inc.
• Pharmaceutical Product Development LLC（PPD）
• Wuxi AppTec Inc.
• Medpace Holdings Inc.
• SGS SA
• Covance Inc.（a subsidiary of LabCorp）
• Celerion Inc.
• Clinipace Worldwide
• Worldwide Clinical Trials Inc.
• Novotech Pty Ltd.
• MMS Holdings Inc.
• Premier Research Group Ltd.
• Medidata Solutions Inc.
• Anavex Life Sciences Corp.
• Cromsource Srl

Global Clinical Trials Support Services Market size was valued at USD 20.86 billion in 2022 and is poised to grow from USD 22.42 billion in 2023 to USD 39.99 billion by 2031, at a CAGR of 7.50% during the forecast period (2024-2031).

Clinical trial support services, assay design, and clinical testing are all highly beneficial. It also involves maintaining kits, calculating drug dosages, protecting clinical test sites, and securing and storing research drugs. Preclinical foundation and research are provided by clinical test support services, which also include assistance with clinical test sites, obtaining and storing study medicines, blinding study drugs, recruiting patients, coordinating, and reconciling returned pharmaceuticals. The clinical trial sector saw substantial transformation in 2021. As COVID-19 vaccinations were developed, many clinical trials that had been delayed due to the pandemic were reopened. Clinical trials are required in order to create novel medications for therapy, as there are many unfulfilled requests in this regard. This is because developing countries have higher rates of infectious, chronic, and tropical diseases. The utilization of virtual clinical trials has been a major factor in the post-pandemic revenue expansion of the industry's clinical trials support services sector. A growing number of clinical research companies are focusing on the use of virtual technologies to streamline their clinical research services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trials Support Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trials Support Services Market Segmental Analysis

The clinical trials support market is segmented into phases, indication and sponsor. The Clinical Trials Support Services Market is divided into four phases: phases I, II, III, and IV. The Clinical Trials Support Services Market is divided into categories for autoimmune/inflammation, oncology, diabetes, cardiovascular, and others based on indication. The Clinical Trials Support Services Market is divided into pharmaceutical and biopharmaceutical businesses, medical device companies, and other companies based on the sponsor. Based on Region Clinical Trials Support Services Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Clinical Trials Support Services Market

The primary drivers of the market's growth include the increased prevalence of infectious and chronic diseases, pharmaceutical companies' large R&D expenditures, the rise of contract research organizations, and the need for clinical trials in developing nations.

Restraints in the Global Clinical Trials Support Services Market

The absence of advanced medical technology and infrastructure is impeding the market's growth. Rigid patient recruiting policies and insufficient trial management frameworks are further major barriers impeding the overall growth of the global clinical trial support services market. Nevertheless, the globalization of clinical trials and the evolution of technology brought about by continuous research and development present a profitable opportunity.

Market Trends of the Global Clinical Trials Support Services Market

The growing need for trials in developing countries, increased investment in research and development, and an increase in the quantity of contract research organizations are all indicators of the global market's rapid expansion (CROs). The pharmaceutical corporations have been increasing their research and development (R&D) investment annually, primarily due to the expiration of patents.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Clinical Trials Support Services Market by Phase

• Market Overview
• phases I
• II
• III
• and IV

Global Clinical Trials Support Services Market by Indication

• Market Overview
• Autoimmune/Inflammation
• Oncology
• Diabetes
• Cardiovascular

Global Clinical Trials Support Services Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• IQVIA Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (a subsidiary of Pamplona Capital Management)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaceutical Product Development LLC (PPD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (a subsidiary of LabCorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech Pty Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMS Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anavex Life Sciences Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cromsource Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments